The Sleep Quality Evidence Guide: What the Research Actually Says

Poor sleep is one of the most common complaints among adults in the UK, yet the supplement aisle remains a graveyard of overclaimed products and undersupported ingredients. This guide cuts through that noise. I've reviewed the peer-reviewed literature on the primary mechanisms governing sleep architecture, the nutrients and compounds with credible evidence behind them, and the specific doses at which effects have been demonstrated. The goal is not to sell you a bedtime ritual — it is to give you an honest, evidence-grounded account of what sleep quality means physiologically, what disrupts it, and what the science suggests may support it.

Sleep quality is not simply duration. It encompasses sleep latency (how long it takes to fall asleep), sleep efficiency (the proportion of time in bed actually spent asleep), sleep architecture (the cycling of NREM and REM stages), and subjective restoration. Each of these dimensions has distinct neurobiological underpinnings, and each responds differently to nutritional and behavioural interventions. Understanding that distinction is the foundation of any serious approach to improving how you sleep.

The Neuroscience of Sleep Architecture

Sleep is not a passive state. It is an actively regulated process governed by competing neuronal systems that cycle through distinct stages across the night. The architecture of a full night's sleep comprises multiple 90-minute cycles, each containing lighter NREM stages, slow-wave sleep (SWS), and REM sleep. These stages serve different restorative functions — from cellular repair and memory consolidation during SWS to emotional processing during REM.

The mechanisms controlling REM sleep in particular are now reasonably well characterised. Glutamatergic neurons in the pons drive the onset and maintenance of REM, while GABAergic and glycinergic inputs produce the characteristic muscle atonia that prevents us from acting out dreams. Luppi 2025 provides a thorough account of the neuronal network controlling REM sleep onset and maintenance, noting that the interplay between excitatory and inhibitory circuits is considerably more nuanced than earlier flip-flop switch models suggested.

The broader sleep-wake cycle is orchestrated by the interaction of multiple arousal systems — serotonergic, noradrenergic, cholinergic, and hypocretinergic — competing against sleep-promoting GABAergic and adenosinergic pathways. Luppi 2019 outlines how waking is maintained by the activity of these ascending arousal systems, and how their progressive inhibition at sleep onset allows the hypothalamic sleep-promoting centres to gain dominance.

What this means practically: interventions that support GABAergic tone, reduce arousal system hyperactivity, or modulate adenosine accumulation are mechanistically plausible candidates for improving sleep quality. This is not merely theoretical — it is the same logic that underpins most pharmacological sleep aids, and it provides a rational framework for evaluating nutritional approaches.

Why Sleep Quality Deteriorates: The Key Disruptors

Before examining what may support sleep, it is worth being precise about what undermines it. The most common disruptors in the 30–60 age bracket are not mysterious: they are chronic psychological stress, dysregulated cortisol rhythms, nutritional insufficiencies, and the progressive decline in melatonin secretion that accompanies ageing.

Melatonin, produced by the pineal gland in response to darkness, is the primary hormonal signal that communicates time-of-night to the circadian system. Its secretion declines markedly with age — a decline that correlates inversely with the increasing prevalence of poor sleep quality in older adults. Poza 2023 notes that melatonin deficit is at least partly responsible for the sleep disturbances observed in ageing populations, and that exogenous supplementation has a rational basis in this context.

Stress-related hyperarousal is the other dominant mechanism. Elevated evening cortisol, rumination, and sympathetic nervous system activation all delay sleep onset and fragment sleep architecture. This is not merely subjective — it is measurable in polysomnographic studies as reduced SWS, increased NREM stage 1, and shortened REM cycles.

Micronutrient insufficiency is a less-discussed but clinically relevant contributor. Magnesium, zinc, and vitamin D have all been identified as nutrients whose insufficiency correlates with impaired sleep parameters. Esquivel 2025 reviews the current evidence on common dietary supplements for sleep quality, noting that physiological mechanisms support the potential role of magnesium, zinc, and vitamin D in sleep regulation, even if the clinical trial evidence remains heterogeneous.

Melatonin: What the Evidence Actually Shows

Melatonin is the most studied sleep-related compound in the literature, and also one of the most misunderstood in popular usage. It is not a sedative. It is a chronobiotic — a signal that shifts the timing of the circadian clock and prepares the body for sleep without directly inducing sedation. This distinction matters enormously for how it should be used.

The evidence on melatonin's sleep-promoting effects is now substantial, though the heterogeneity of dosing protocols has historically made interpretation difficult. A systematic review and dose-response meta-analysis by Cruz-Sanabria 2024 examined double-blind randomised controlled trials in patients with insomnia and circadian rhythm disorders, finding that timing and dose both significantly modulate efficacy. Lower doses (0.5–1mg) taken 1–2 hours before desired sleep onset appear most effective for circadian phase-shifting, while higher doses may be more appropriate for older adults with blunted endogenous secretion.

Duffy 2022 specifically examined high-dose melatonin in older adults, finding that it increased sleep duration during both nighttime and daytime sleep episodes — a finding with implications for the age-related sleep disruption discussed above.

It is worth noting that in the UK, melatonin is a prescription-only medicine above 0.3mg. KōJō Daily Formula does not contain melatonin. The relevance here is mechanistic: understanding how melatonin works informs why supporting the conditions for endogenous melatonin production — reducing evening light exposure, managing stress, ensuring adequate magnesium — is a rational strategy.

L-Theanine: The Most Credible Non-Sedative Sleep Ingredient

L-theanine is a non-proteinogenic amino acid found predominantly in green tea. Its mechanism of action is distinct from sedative compounds: rather than inducing drowsiness, it appears to reduce physiological and psychological arousal, facilitating the transition to sleep without next-day impairment. This profile makes it particularly relevant for stress-related sleep disruption.

The evidence base has strengthened considerably. A 2025 systematic review and meta-analysis by Bulman 2025 evaluated randomised controlled trials examining L-theanine's effects on sleep outcomes, finding improvements in sleep quality, sleep latency, and sleep efficiency. The effect sizes were modest but consistent across study populations.

The mechanistic picture is reasonably clear. L-theanine promotes alpha-wave activity in the brain — a pattern associated with relaxed alertness — and modulates GABAergic and glutamatergic neurotransmission. Kim 2019 demonstrated that a GABA and L-theanine combination decreased sleep latency and improved NREM sleep in animal models, suggesting synergistic activity between these pathways.

Dasdelen 2022 examined a novel magnesium–L-theanine complex, finding that the combination improved sleep quality via regulation of brain electrochemical activity — a finding that points toward the potential additive value of combining these two compounds.

In a randomised controlled trial, Hidese 2020 found that 200mg/day of L-theanine over four weeks improved sleep-related symptoms in healthy adults, alongside reductions in stress-related measures. The dose used in that trial — 200mg — is exactly the dose present in KōJō Daily Formula.

Magnesium, Glycine, and the GABAergic Pathway

Magnesium is one of the most physiologically significant minerals for sleep regulation, and one of the most commonly insufficient in adults eating a typical Western diet. Its relevance to sleep operates through several mechanisms: it is a natural NMDA receptor antagonist, a co-factor in melatonin synthesis, and a modulator of GABA-A receptor activity. Dasdelen 2022 highlights magnesium's role as a GABA agonist and NMDA antagonist in the context of sleep regulation — mechanisms that are directly relevant to reducing nocturnal arousal and improving sleep continuity.

The form of magnesium matters. Magnesium bisglycinate — the form used in KōJō Daily Formula at 1000mg (delivering 200mg elemental magnesium) — has superior bioavailability compared to oxide or citrate forms, and the glycinate component itself carries additional relevance.

Glycine is a non-essential amino acid with a distinct and well-characterised role in sleep. It acts as an inhibitory neurotransmitter in the spinal cord and brainstem, and — critically — contributes to the thermoregulatory mechanism that facilitates sleep onset. Core body temperature must fall by approximately 1°C for sleep onset to occur; glycine appears to support this process by promoting peripheral vasodilation. Langan-Evans 2023 included glycine as part of a nutritional blend that improved both subjective and objective sleep measures in a double-blind, randomised, repeated-measures design — one of the more methodologically rigorous nutritional sleep studies available.

KōJō Daily Formula provides 2000mg of glycine as a standalone ingredient, alongside 1000mg magnesium bisglycinate. The combination addresses both GABAergic tone and thermoregulatory sleep onset mechanisms through complementary pathways.

Adaptogens and Stress-Mediated Sleep Disruption

For a substantial proportion of adults, poor sleep quality is not a primary sleep disorder — it is a downstream consequence of chronic stress and the associated hyperarousal. In this context, addressing the stress response directly is a mechanistically coherent strategy for improving sleep.

Ashwagandha (Withania somnifera) has the most substantial clinical evidence base among adaptogens for sleep-related outcomes. A systematic review and meta-analysis by Cheah 2021 found that ashwagandha extract had a small but significant effect on overall sleep quality, sleep onset latency, and morning alertness. The effect was more pronounced in participants with insomnia and in those taking doses of 600mg or above for at least eight weeks.

Two RCTs by Langade and colleagues provide more granular data. Langade 2020 found that ashwagandha root extract (300mg twice daily) significantly improved sleep quality and anxiety in patients with insomnia, while Langade 2021 extended these findings to healthy volunteers, confirming improvements in sleep efficiency, sleep latency, and total sleep time versus placebo. The proposed mechanism involves modulation of the hypothalamic-pituitary-adrenal axis and GABAergic activity — pathways that directly intersect with the arousal systems discussed in section one.

Speers 2021 provides a broader review of ashwagandha's effects on stress-related neuropsychiatric conditions including insomnia, concluding that the evidence supports its use as an adaptogen with genuine neuropsychiatric relevance.

It is worth noting that KōJō Daily Formula does not currently contain ashwagandha. However, it does contain Rhodiola rosea extract at 350mg — another adaptogen with evidence for reducing stress-related fatigue and supporting psychological resilience, though the direct sleep-quality evidence for Rhodiola is less developed than for ashwagandha.

Herbal Compounds and Supporting Evidence

Beyond the primary ingredients above, a broader range of botanical compounds has been investigated for sleep-related effects. The evidence quality varies considerably, and intellectual honesty requires distinguishing between compounds with RCT support and those with only mechanistic or observational data.

Valerian, passionflower, lemon balm, and lavender have all been examined in the context of anxiety-related insomnia. Borrás 2021 reviewed the evidence for medicinal plants used in insomnia related to anxiety, finding that while several botanical preparations showed promising results in small trials, the methodological quality of the evidence base remains limited. The most consistent findings were for preparations combining multiple herbs, suggesting potential synergistic mechanisms rather than single-compound effects.

The role of taurine — present in KōJō Daily Formula at 2000mg — is worth noting in this context. Taurine is an amino acid with GABAergic and glycinergic properties; it modulates inhibitory neurotransmission and has been identified as a neuromodulator with potential relevance to sleep regulation. The direct clinical evidence for taurine's sleep effects in humans is limited, and I would not overstate this claim — but the mechanistic rationale is coherent within the GABAergic framework established throughout this article.

The nutritional blend study by Langan-Evans 2023 is instructive here: it demonstrated that combinations of sleep-relevant nutrients — in that case tryptophan, glycine, magnesium, tart cherry, and L-theanine — produced measurable improvements in sleep latency, duration, and efficiency. This supports the principle that multi-ingredient approaches targeting complementary mechanisms may produce additive effects, even when individual ingredient evidence is modest.

Vitamin D, Zinc, and Micronutrient Sufficiency

The relationship between micronutrient status and sleep quality is frequently underappreciated in clinical practice. Vitamin D and zinc in particular have mechanistic links to sleep regulation that go beyond simple correlation.

Vitamin D receptors are expressed in brain regions involved in sleep regulation, including the hypothalamus and brainstem. Low vitamin D status has been associated with shorter sleep duration and poorer sleep quality in epidemiological studies, though the direction of causality remains debated. Esquivel 2025 identifies vitamin D as one of the common dietary supplements with physiological mechanisms supporting potential impact on sleep quality, while noting that the clinical trial evidence remains heterogeneous.

Zinc plays a role in the synthesis of melatonin and in GABAergic neurotransmission. Insufficiency has been associated with disrupted sleep architecture in observational data. EFSA's NHC register approves the wording "zinc contributes to normal cognitive function" — a claim that, while not sleep-specific, reflects the broader neurological role of zinc in brain function.

KōJō Daily Formula provides 50mcg of vitamin D3 (equivalent to 2000 IU) — a dose that comfortably addresses the insufficiency that is endemic in the UK population, particularly during winter months — alongside 53mg zinc bisglycinate (delivering 16mg elemental zinc), a highly bioavailable form that supports micronutrient sufficiency without excess.

Magnesium, discussed in detail above, rounds out the micronutrient picture. EFSA's NHC register approves the wording "magnesium contributes to normal psychological function" and "magnesium contributes to the reduction of tiredness and fatigue" — claims that are directly relevant to the sleep quality context.

What KōJō Daily Formula Does for Sleep Quality

KōJō Daily Formula is not a sleep supplement. It is a comprehensive daily formula designed to support multiple dimensions of health in research-driven adults. However, several of its ingredients have direct mechanistic relevance to sleep quality, and the doses used align with those studied in the clinical literature.

The following ingredients in KōJō Daily Formula are relevant to sleep quality:

L-Theanine — 200mg The dose used in Hidese 2020's RCT showing improvements in sleep-related symptoms in healthy adults. Supports alpha-wave activity and reduces physiological arousal without sedation. Bulman 2025's meta-analysis confirms improvements in sleep latency and efficiency at this dose range.

Glycine — 2000mg Included as a standalone ingredient. Contributes to sleep onset via thermoregulatory mechanisms and inhibitory neurotransmission. Featured as a component of the multi-ingredient sleep blend studied by Langan-Evans 2023.

Magnesium Bisglycinate — 1000mg (200mg elemental) Supports GABAergic tone and NMDA receptor modulation relevant to sleep regulation. Dasdelen 2022 highlights magnesium's role as a GABA agonist and NMDA antagonist in sleep quality research. EFSA approves magnesium as contributing to normal psychological function and reduction of tiredness and fatigue.

Taurine — 2000mg An amino acid with GABAergic and glycinergic neuromodulatory properties. Direct clinical sleep evidence in humans is limited; the mechanistic rationale within the inhibitory neurotransmission framework is coherent.

Zinc Bisglycinate — 53mg (16mg elemental) Supports melatonin synthesis and GABAergic neurotransmission. Esquivel 2025 identifies zinc as a micronutrient with physiological mechanisms relevant to sleep quality.

Vitamin D3 — 50mcg Addresses the endemic insufficiency in the UK adult population. Vitamin D receptors are expressed in sleep-relevant brain regions; Esquivel 2025 identifies vitamin D among the supplements with mechanistic support for sleep quality.

Rhodiola Rosea Extract — 350mg An adaptogen targeting stress-related fatigue. While direct sleep RCT evidence for Rhodiola is less developed than for ashwagandha, its mechanism — modulation of the stress response — addresses one of the primary upstream drivers of poor sleep quality in adults.

Vitamin B6 — 2.8mg A co-factor in the synthesis of serotonin and melatonin from tryptophan. Supports the endogenous melatonin production pathway without the regulatory complications of exogenous melatonin supplementation.

Vitamin B12 — 500mcg Involved in circadian rhythm regulation and melatonin synthesis. Insufficiency has been associated with disrupted sleep-wake cycles in observational studies.

The evidence reviewed here reflects the state of the published literature as of mid-2025. Sleep quality is a multifactorial outcome, and no single supplement or formula replaces consistent sleep hygiene, appropriate light management, and stress reduction as the primary foundations of restorative sleep. KōJō Daily Formula is designed to complement — not substitute for — those foundations.

Frequently Asked Questions